Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

High-Sensitivity Cardiac Troponin T: Association of Creatine Kinase Catalytic Activity With the 99th Percentile.

Masuch A, Ittermann T, Greinacher A, Lubenow N, Kohlmann T, Nauck M, Petersmann A.

Clin Chem. 2018 Jun;64(6):973-974. doi: 10.1373/clinchem.2017.285775. Epub 2018 Apr 13. No abstract available.

PMID:
29653935
2.

Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years

Cherif H, Greinacher A, Lubenow N.

Lakartidningen. 2018 Mar 13;115. pii: EY3I. Swedish.

3.

The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population.

Greiser A, Winter T, Mahfoud H, Kallner A, Ittermann T, Masuch A, Lubenow N, Kohlmann T, Greinacher A, Nauck M, Petersmann A.

Clin Biochem. 2017 Dec;50(18):1198-1202. doi: 10.1016/j.clinbiochem.2017.08.006. Epub 2017 Aug 10.

PMID:
28803961
4.

Motivational factors for blood donation in first-time donors and repeat donors: a cross-sectional study in West Pomerania.

Suemnig A, Konerding U, Hron G, Lubenow N, Alpen U, Hoffmann W, Kohlmann T, Greinacher A.

Transfus Med. 2017 Dec;27(6):413-420. doi: 10.1111/tme.12450. Epub 2017 Aug 7.

PMID:
28786224
5.

An evaluation of the mixed pediatric unit for blood loss replacement in pediatric craniofacial surgery.

Mogensen S, Lubenow N, Nilsson P, Engquist H, Knutsson F, Enblad P, Nowinski D, Frykholm P.

Paediatr Anaesth. 2017 Jul;27(7):711-717. doi: 10.1111/pan.13140. Epub 2017 Apr 23.

PMID:
28436074
6.

Standardizing the freeze-thaw preparation of growth factors from platelet lysate.

Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F, Berglund D.

Transfusion. 2017 Apr;57(4):1058-1065. doi: 10.1111/trf.13998. Epub 2017 Feb 9.

PMID:
28182293
7.

Analysis of thromboelastography, PT, APTT and fibrinogen in intraosseous and venous samples-an experimental study.

Strandberg G, Lipcsey M, Eriksson M, Lubenow N, Larsson A.

Scand J Trauma Resusc Emerg Med. 2016 Nov 3;24(1):131.

8.

Impact of physical activity of individuals and creatine kinase on 99th percentiles of troponin I assays.

Petersmann A, Ittermann T, Frieß C, Lubenow N, Kohlmann T, Greinacher A, Masuch A, Nauck M.

Clin Chim Acta. 2016 Nov 1;462:187-192. doi: 10.1016/j.cca.2016.10.002. Epub 2016 Oct 3.

PMID:
27712987
9.

Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units.

Sellberg F, Berglund E, Ronaghi M, Strandberg G, Löf H, Sommar P, Lubenow N, Knutson F, Berglund D.

Transfus Apher Sci. 2016 Dec;55(3):333-337. doi: 10.1016/j.transci.2016.08.004. Epub 2016 Sep 28.

PMID:
27720587
10.

Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinic.

Greinacher A, Lubenow N.

Vox Sang. 2016 Jul;111(1):3-7. doi: 10.1111/vox.12379. Epub 2016 Feb 18.

PMID:
26890279
11.

Green plasma.

Berglund D, Lindvall P, Lubenow N.

Transfusion. 2015 Feb;55(2):245. doi: 10.1111/trf.12741. No abstract available.

PMID:
25683187
12.

Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test.

Hron G, Knutson F, Thiele T, Althaus K, Busemann C, Friesecke S, Greinacher A, Lubenow N.

Ups J Med Sci. 2013 Nov;118(4):279-84. doi: 10.3109/03009734.2013.838811.

13.

Comparison of the 99th percentiles of three troponin I assays in a large reference population.

Petersmann A, Ittermann T, Fries C, Lubenow N, Kohlmann T, Kallner A, Greinacher A, Nauck M.

Clin Chem Lab Med. 2013 Nov;51(11):2181-6. doi: 10.1515/cclm-2013-0113.

PMID:
23846150
14.

Prophylactic platelet transfusions.

Pietersz RN, Reesink HW, Panzer S, Gilbertson MP, Borosak ME, Wood EM, Leitner GC, Rabitsch W, Ay C, Lambermont M, Deneys V, Sondag D, Compernolle V, Legrand D, François A, Tardivel R, Garban F, Sawant RB, Rebulla P, Handa M, Ohto H, Kerkhoffs JL, Brand A, Zhiburt E, Cid J, Escolar G, Lozano M, Puig L, Knutson F, Hallböök H, Lubenow N, Estcourt L, Stanworth S, Murphy MF, Williams L, Mraz DL, Ross RL, Snyder E.

Vox Sang. 2012 Aug;103(2):159-76. doi: 10.1111/j.1423-0410.2012.01595.x. Epub 2012 Apr 20. No abstract available.

PMID:
22519879
15.

Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests.

Greinacher A, Ittermann T, Bagemühl J, Althaus K, Fürll B, Selleng S, Lubenow N, Schellong S, Sheppard JI, Warkentin TE.

J Thromb Haemost. 2010 Sep;8(9):2025-31. doi: 10.1111/j.1538-7836.2010.03974.x.

16.

The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, Jünger M, Nauck M, Schellong S, Wander K, Engel G, Ekkernkamp A, Greinacher A.

Blood. 2010 Mar 4;115(9):1797-803. doi: 10.1182/blood-2009-07-231506. Epub 2009 Nov 20.

17.

[Thrombosis prophylaxis in trauma surgery units in Germany: a survey].

Hinz P, Lubenow N, Wessel A, Greinacher A, Ekkernkamp A.

Unfallchirurg. 2009 Dec;112(12):1029-33. doi: 10.1007/s00113-008-1557-y. German.

PMID:
19859680
18.

Heparin-induced thrombocytopenia: recommendations for optimal use of recombinant hirudin.

Lubenow N, Greinacher A.

BioDrugs. 2000 Aug;14(2):109-25.

PMID:
18034563
19.
20.

Profiling of alterations in platelet proteins during storage of platelet concentrates.

Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, Lubenow N, Clemetson KJ, Völker U, Greinacher A.

Transfusion. 2007 Jul;47(7):1221-33.

PMID:
17581157
21.

Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.

Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE.

J Thromb Haemost. 2007 Aug;5(8):1666-73. Epub 2007 May 7.

22.

IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.

Schenk S, El-Banayosy A, Morshuis M, Arusoglu L, Eichler P, Lubenow N, Tenderich G, Koerfer R, Greinacher A, Prohaska W.

J Thromb Haemost. 2007 Feb;5(2):235-41. Epub 2006 Oct 31.

23.
24.

Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.

Lubenow N, Eichler P, Lietz T, Greinacher A; Hit Investigators Group.

J Thromb Haemost. 2005 Nov;3(11):2428-36.

26.

New developments in diagnosis and treatment of heparin-induced thrombocytopenia.

Lubenow N.

Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):407-12. Review.

27.

Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies.

Lubenow N, Eichler P, Lietz T, Farner B, Greinacher A.

Blood. 2004 Nov 15;104(10):3072-7. Epub 2004 Jul 27.

28.

Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.

Speiser DE, Pittet MJ, Guillaume P, Lubenow N, Hoffman E, Cerottini JC, Romero P.

J Immunother. 2004 Jul-Aug;27(4):298-308.

PMID:
15235391
29.

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Liénard D, Lejeune F, Rimoldi D, Guillaume P, Meidenbauer N, Mackensen A, Rufer N, Lubenow N, Speiser D, Cerottini JC, Romero P, Pittet MJ.

Cancer Res. 2004 Apr 15;64(8):2865-73.

30.

Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature.

Klenner AF, Lubenow N, Raschke R, Greinacher A.

Thromb Haemost. 2004 Apr;91(4):719-24. Review.

PMID:
15045133
31.

Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.

Lubenow N, Greinacher A.

Am J Cardiovasc Drugs. 2001;1(6):429-43. Review.

PMID:
14728002
32.

CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro.

Rothenfusser S, Hornung V, Ayyoub M, Britsch S, Towarowski A, Krug A, Sarris A, Lubenow N, Speiser D, Endres S, Hartmann G.

Blood. 2004 Mar 15;103(6):2162-9. Epub 2003 Nov 20.

33.

Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.

Greinacher A, Lubenow N, Eichler P.

Circulation. 2003 Oct 28;108(17):2062-5. Epub 2003 Oct 20.

PMID:
14568897
34.

[Informed consent on heparin-induced thrombocytopenia during thrombosis prophylaxis. A pilot study including 460 patients].

Hinz P, Lubenow N, Ekkernkamp A, Greinacher A.

Dtsch Med Wochenschr. 2003 Oct 17;128(42):2184-8. German.

PMID:
14562216
35.

Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin.

Eichler P, Lubenow N, Strobel U, Greinacher A.

Blood. 2004 Jan 15;103(2):613-6. Epub 2003 Sep 25.

36.

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.

Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S.

Eur J Immunol. 2003 Jun;33(6):1633-41.

37.

Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia.

Carlsson LE, Lubenow N, Blumentritt C, Kempf R, Papenberg S, Schröder W, Eichler P, Herrmann FH, Santoso S, Greinacher A.

Pharmacogenetics. 2003 May;13(5):253-8.

PMID:
12724616
38.

Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.

Lubenow N, Selleng S, Wollert HG, Eichler P, Müllejans B, Greinacher A.

Ann Thorac Surg. 2003 Feb;75(2):577-9.

PMID:
12607680
39.

Hirudin in heparin-induced thrombocytopenia.

Lubenow N, Greinacher A.

Semin Thromb Hemost. 2002 Oct;28(5):431-8. Review.

PMID:
12420238
40.

[Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia].

Hinz P, Lubenow N, Eckernkamp A, Geinacher A.

Unfallchirurg. 2002 Sep;105(9):845-50. German.

PMID:
12232745
41.

[Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis].

Lubenow N, Greinacher A.

Hamostaseologie. 2002 Aug;22(3):44-54. Review. German.

PMID:
12215761
42.

Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin.

Lubenow N, Kempf R, Eichner A, Eichler P, Carlsson LE, Greinacher A.

Chest. 2002 Jul;122(1):37-42.

PMID:
12114336
43.

The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays.

Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A.

Br J Haematol. 2002 Mar;116(4):887-91.

PMID:
11886396
44.

Drug-induced and drug-dependent immune thrombocytopenias.

Greinacher A, Eichler P, Lubenow N, Kiefel V.

Rev Clin Exp Hematol. 2001 Sep;5(3):166-200; discussion 311-2. Review.

PMID:
11703814
45.

Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia.

Weimann G, Lubenow N, Selleng K, Eichler P, Albrecht D, Greinacher A.

Eur J Haematol. 2001 Mar;66(3):195-9.

PMID:
11350488
46.

Emergency cardiopulmonary bypass in a bilaterally nephrectomized patient with a history of heparin-induced thrombocytopenia: successful reexposure to heparin.

Selleng S, Lubenow N, Wollert HG, Müllejans B, Greinacher A.

Ann Thorac Surg. 2001 Mar;71(3):1041-2.

PMID:
11269430
47.

Recombinant hirudin in clinical practice: focus on lepirudin.

Greinacher A, Lubenow N.

Circulation. 2001 Mar 13;103(10):1479-84. Review.

PMID:
11245656
48.

Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Lubenow N, Greinacher A.

J Thromb Thrombolysis. 2000 Nov;10 Suppl 1:47-57. Review. No abstract available.

PMID:
11155194
49.

Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: coincidence or association?

Schwarzinger I, Speiser W, Lubenow N, Greinacher A, Panzer S.

Thromb Haemost. 2000 Dec;84(6):1123-4. No abstract available.

PMID:
11154128
50.

Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature.

Lubenow N, Eichler P, Albrecht D, Carlsson LE, Kothmann J, Rossocha WR, Hahn M, Quitmann H, Greinacher A.

Thromb Res. 2000 Nov 1;100(3):115-25. Review.

PMID:
11108897

Supplemental Content

Loading ...
Support Center